Free public records show Esjay Pharma in 2 of the markets we cover. It is not a key player in our research.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
7 approvals with a product on the US market
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.
Markets we cover where free public records show Esjay Pharma: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Esjay Pharma is in.
Stories on the topics Esjay Pharma works in.
Anaemia affects about half a billion women worldwide, and folic acid before pregnancy prevents serious birth…
Read
Iron supplements are the first line against anaemia. Why taking them is the hard part, and how the market is…
Read
Vitamin B12 comes almost only from animal foods. Vegetarians, older adults and people on some medicines are…
Read